Clinical Trial Update: Effect of Donor Chose on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG/PTCy for Haplo-HSCT

View source ↗

Summary

This clinical trial registry entry describes a study evaluating whether donor selection affects graft-versus-host disease prophylaxis outcomes when using a comb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: High-Risk Acute Myeloid Leukemia, Relapse And/or Refractory AML | Status: NOT_YET_RECRUITING